https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-01 / Methods Mol. Biol. 2014;1139:33-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-01 / Methods Mol. Biol. 2014;1139:33-402014-01-01 00:00:002019-02-15 08:39:43Antigen trapping by dendritic cells for antitumor therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-01 / Hum Vaccin Immunother 2014;10(11):3261-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-01 / Hum Vaccin Immunother 2014;10(11):3261-92014-01-01 00:00:002019-02-15 08:39:33Tumor cell lysates as immunogenic sources for cancer vaccine design
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-01 / CNS Oncol 2014;3(5):337-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-01 / CNS Oncol 2014;3(5):337-482014-01-01 00:00:002019-02-15 08:32:55Diffuse intrinsic pontine glioma: time for therapeutic optimism
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-01 / Hum Vaccin Immunother 2014;10(11):3125-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-01 / Hum Vaccin Immunother 2014;10(11):3125-312014-01-01 00:00:002019-02-15 08:32:45Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
